Date:9/10/2012

search and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For press releases and additional information about the company, please visit www.amriglobal.com.

 

 

 

'/>"/>

SOURCE AMRI Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related medicine technology :

1. Nile Therapeutics Promotes Darlene Horton, M.D., to Chief Executive Officer and Director
2. Diplomat Specialty Pharmacy Promotes Dr. Atheer Kaddis to Sr. Vice President of Sales and Marketing
3. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
4. Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets
5. Conatus Pharmaceuticals Appoints Daniel Ripley As Head Of Corporate Development
6. Study Confirms Daniels Sharpsmart Helps Hospitals Reduce Carbon Footprint
7. Daniel Sontupe, SVP, Director of Market Access, at The CementBloc, to Present on Uncovering the Value in a Patient Support Program at CBI Summit
8. Okuma America Chooses The Daniel Group To Provide Customer Service Research
9. Catalent Pharma Solutions, Inc. Announces Increase In Tender Cap For Its Cash Tender Offer For Its 9-1/2%/10-1/4% Senior PIK-Election Notes Due 2015
10. Catalent Pharma Solutions, Inc. Announces Cash Tender Offer for up to $250 Million of Its 9-1/2%/10-1/4% Senior PIK-Election Notes due 2015
11. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel